Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Greenyn Biotechnology Co., Ltd. (6846) Financial Statements

Greenyn Biotechnology Co., Ltd. Financial Overview

Greenyn Biotechnology Co., Ltd.'s market cap is currently NT$1.33B. The company's EPS TTM is NT$4.70; its P/E ratio is 12.56; and it has a dividend yield of 8.05%. Greenyn Biotechnology Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Sep 22
Income Statement
Total RevenueNT$ 915.32MNT$ 873.24MNT$ 800.51MNT$ 705.31MNT$ 693.77M
Gross ProfitNT$ 440.04MNT$ 415.23MNT$ 392.46MNT$ 370.93MNT$ 358.02M
Operating IncomeNT$ 188.63MNT$ 167.86MNT$ 159.82MNT$ 185.26MNT$ 170.39M
EBITDANT$ 224.08MNT$ 215.81MNT$ 192.40MNT$ 210.40MNT$ 193.67M
Net IncomeNT$ 145.52MNT$ 146.00MNT$ 130.66MNT$ 146.74MNT$ 132.78M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.15BNT$ 552.53MNT$ 533.66MNT$ 370.45MNT$ 436.30M
Total AssetsNT$ 2.11BNT$ 1.11BNT$ 1.16BNT$ 834.81MNT$ 844.86M
Total DebtNT$ 915.56MNT$ 65.71MNT$ 196.13MNT$ 85.73MNT$ 70.20M
Net DebtNT$ 122.20MNT$ -486.67MNT$ -337.37MNT$ -284.57MNT$ -285.93M
Total LiabilitiesNT$ 1.13BNT$ 257.32MNT$ 364.48MNT$ 272.80MNT$ 231.09M
Stockholders' EquityNT$ 978.56MNT$ 851.35MNT$ 796.91MNT$ 562.01MNT$ 613.76M
Cash Flow
Free Cash FlowNT$ -236.18MNT$ 209.89MNT$ 37.73MNT$ 212.59MNT$ 64.05M
Operating Cash FlowNT$ 158.90MNT$ 219.66MNT$ 127.10MNT$ 229.73MNT$ 81.79M
Investing Cash FlowNT$ -753.95MNT$ 33.77MNT$ -155.75MNT$ -16.41MNT$ -18.82M
Financing Cash FlowNT$ 836.37MNT$ -234.57MNT$ 191.86MNT$ -199.15MNT$ -90.98M

Currency in TWD

Greenyn Biotechnology Co., Ltd. Earnings and Revenue History

0400M800M1.2B15 %17.5 %20 %22.5 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Greenyn Biotechnology Co., Ltd. Liabilities to Assets

0800M1.6B2.4B15 %30 %45 %60 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Greenyn Biotechnology Co., Ltd. Cash Flow

-1B-500M0500M1B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Greenyn Biotechnology Co., Ltd. Forecast EPS vs Actual EPS

0123Q2 25Q3 25Q4 25Q1 26Q3 26EPS EstimateBeatMiss
Earnings >